Literature DB >> 30002017

Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults.

Christopher D Byrne1,2, Janisha Patel3, Eleonora Scorletti4,2, Giovanni Targher5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30002017     DOI： 10.1136/bmj.k2734

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.

Authors:  E Cipponeri; N Vitturi; V Mariano; F Boscari; S Galasso; C Crepaldi; G P Fadini; S Vigili de Kreutzenberg; M C Marescotti; E Iori; F Cavallin; L Sartori; A Baritussio; A Avogaro; D Bruttomesso
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

2.  Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?

Authors:  Giovanni Targher
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

3.  Aerobic Exercise and Metabolic Syndrome: The Role of Sympathetic Activity and the Redox System.

Authors:  Vincenzo Monda; Francesco Sessa; Maria Ruberto; Marco Carotenuto; Gabriella Marsala; Marcellino Monda; Maria Teresa Cambria; Marinella Astuto; Alfio Distefano; Giovanni Messina
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-08       Impact factor: 3.168

Review 4.  The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.

Authors:  Giovanni Targher; Kathleen E Corey; Christopher D Byrne; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-10       Impact factor: 46.802

5.  Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis.

Authors:  Ke Xu; Kenneth I Zheng; Pei-Wu Zhu; Wen-Yue Liu; Hong-Lei Ma; Gang Li; Liang-Jie Tang; Rafael S Rios; Giovanni Targher; Christopher D Byrne; Xiao-Dong Wang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-07-29

Review 6.  Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis.

Authors:  Yong Ho Lee; Yongin Cho; Byung Wan Lee; Cheol Young Park; Dae Ho Lee; Bong Soo Cha; Eun Jung Rhee
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

7.  Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.

Authors:  Kenneth I Zheng; Wen-Yue Liu; Xiao-Yan Pan; Hong-Lei Ma; Pei-Wu Zhu; Xi-Xi Wu; Giovanni Targher; Christopher Byrne; Xiao-Dong Wang; Yong-Ping Chen; Fengmin Lu; Ming-Hua Zheng
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03

8.  Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis.

Authors:  Geraldine F Clough; Andrew J Chipperfield; Marjola Thanaj; Eleonora Scorletti; Philip C Calder; Christopher D Byrne
Journal:  Front Physiol       Date:  2020-06-03       Impact factor: 4.566

9.  Combined effects of lifestyle risk factors on fatty liver index.

Authors:  Ulla Nivukoski; Markus Niemelä; Aini Bloigu; Risto Bloigu; Mauri Aalto; Tiina Laatikainen; Onni Niemelä
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

10.  Newborn and childhood differential DNA methylation and liver fat in school-age children.

Authors:  Madelon L Geurtsen; Vincent W V Jaddoe; Lucas A Salas; Susana Santos; Janine F Felix
Journal:  Clin Epigenetics       Date:  2019-12-31       Impact factor: 6.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.